CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Bylaws or fiscal year change
- 8-K Event Delisting notice
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Other events
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 8-K Event Auditor change
- 8-K Event Bylaws or fiscal year change
- 8-K Event Unregistered share sale · Other events
Page 1 of 26 · 505 filings